GreenLight Clinical establishes European operations in Denmark
Establishing a European headquarter in this premier biopharma location enhances the capability of GreenLight Clinical to manage high-quality trials in Scandinavian and other European countries.
It also consolidates the company as a global CRO with the network and resources to facilitate clinical evaluation of a wide range of medical and healthcare products and drive their commercial development, in both Europe and across the world.
GreenLight Clinical has an established multinational presence in the Asia-Pacific region and has recently expanded into the east coast of the United States with an office in Boston. The addition of a dedicated operations and R&D base in Denmark offers a full suite of clinical research services to the thriving local biopharma sector and provides it with streamlined access to the global markets in which GreenLight Clinical operates.
“This is an exciting development for GreenLight Clinical,” says Dr. Sasi Suda, CEO of GreenLight Clinical.
We are very much aware of the quality, diversity and innovation of medical research in Denmark’s universities and private sector. Together with the Danish Government’s Invest in Denmark support for foreign ventures, it made Copenhagen an obvious choice for our European headquarters. We will be looking to put specialist teams together here very soon to conduct and develop quality trials that advance products from local and regional programs. But more than this, we believe that our global study sponsors will be very interested in what the European arm of our business can offer them as they pursue the clinical development of their products.
GreenLight Clinical has invested in developing sound service networks at all its operation sites. These not only support research within individual domestic markets but also enhance cross-market collaborations. The Copenhagen headquarters is part of this broader network that GreenLight Clinical believes will serve the current and future needs of the company’s study sponsors.
This expansion into Denmark fits well with our aim to be the partner of choice for companies seeking optimised clinical development and ongoing commercial opportunities in significant world markets.
Together with Copenhagen Capacity, Invest in Denmark has advised GreenLight Clinical in the process of setting up its new European base in Copenhagen. Steen Hommel, Director of Invest in Denmark, is pleased to welcome GreenLight Clinical to Denmark:
We are extremely happy that Greenlight Clinical have chosen Denmark for their European headquarter. It confirms that Denmark offers a competitive business environment and the right competences for developing life sciences services, especially with a strong tradition for doing medical research.
About GreenLight Clinical
GreenLight Clinical is based in Sydney (Australia), with additional offices in Bangkok (Thailand), Seoul (South Korea), Nanjing (China), Boston (USA) and a European base in Copenhagen (Denmark).